1. SARS-CoV-2 seroprevalence in preschool and school-age children
- Author
-
Ott, R., Achenbach, P., Ewald, D.A., Friedl, N., Gemulla, G., Hubmann, M., Kordonouri, O., Loff, A., Marquardt, E., Sifft, P., Sporreiter, M.S., Zapardiel-Gonzalo, J., and Ziegler, A.-G.
- Subjects
General Medicine - Abstract
BACKGROUND: The SARS-CoV-2 pandemic is ongoing in Germany. Children and adolescents are increasingly being infected, and many cases presumably remain undetected and unreported. Sero-epidemiological studies can help estimate the true number of infections. METHODS: From January 2020 to June 2022, 59 786 persons aged 1-17 years were tested for SARS-CoV-2 antibodies as part of a screening program for presymptomatic type 1 diabetes in the German federal state of Bavaria (the Fr1da study). RESULTS: In June 2022, the seroprevalence in the overall population was 73.5%. The seroprevalence was significantly higher in school-age children (from 5 to 10 years of age) than in preschool children (ages 1-4): 84.4% vs. 66.6%, p
- Published
- 2022
- Full Text
- View/download PDF